Complications and Long-term Satisfaction in Autologous vs. Implant-Based Breast Reconstruction
The Complex Relationship of Complications and Patient-reported Outcome Measures in Autologous Versus Alloplastic Breast Reconstruction.
1 other identifier
observational
162
1 country
1
Brief Summary
Current literature on complications and health-related quality of life in autologous and alloplastic breast reconstruction is inconclusive. Despite the great demand for more in-depth, long-term studies of both techniques, current evidence is low or moderate and there are only few studies focusing on both health-related quality of life and complication rates in the same patient collective. This study aims at investigating the complex relationship between the occurrence of complications and patient-reported long-time satisfaction in autologous and alloplastic breast reconstruction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 27, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedMarch 6, 2024
March 1, 2024
4.1 years
February 27, 2024
March 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Complications
The five-level modified Clavien-Dindo classification is used to objectively classify postoperative complications. A subgroup analysis will be done for complications requiring revision surgery under general anesthesia and complications not requiring revision surgery under general anesthesia.
Retrospective data analysis at the time of study inclusion (up to 10 years postoperative)
Secondary Outcomes (1)
Health-related quality of life and satisfaction
Retrospective data analysis at the time of study inclusion (up to 10 years postoperative)
Study Arms (2)
Autologous Breast Reconstruction
Patients undergoing autologous breast reconstruction with free flaps
Alloplastic Breast Reconstruction
Patients undergoing alloplastic breast reconstruction with implants or expander prosthesis
Interventions
Patient-reported outcome measure
Eligibility Criteria
Female breast cancer patients between 18 and 80 years who underwent autologous or alloplastic breast reconstruction at our department, willing to participate in this study.
You may qualify if:
- female breast cancer patient undergoing autologous or alloplastic breast reconstruction willing to participate in this study
- age between 18 and 80 years (upper limit due to indication for breast reconstruction)
- written informed consent
You may not qualify if:
- Missing or insufficient information
- combination of reconstruction techniques on the same breast
- reconstruction procedures with insufficient number of cases
- inability to fully understand study procedures and to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Graz
Graz, 8036, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2024
First Posted
March 6, 2024
Study Start
October 10, 2019
Primary Completion
November 28, 2023
Study Completion
February 1, 2024
Last Updated
March 6, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, CSR
- Time Frame
- Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis
Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).